PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT

• Auteurs principaux: N. K. Mazina (Auteur), P. V. Mazin (Auteur), Yu. V. Kislitsin (Auteur), E. M. Markova (Auteur)
• Format: Livre
• Publié: IRBIS LLC, 2016-04-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Among epileptic encephalopathies, the Lennox-Gastaut syndrome is considered to be one of the most severe. It is a childhood-onset disease that leads to early disability and mental retardation and is associated with significant costs of medical care and patient nursing. In the Russian Federation, the...